|
1
|
Griffin JF, Page AJ, Samaha GJ,
Christopher A, Bhaijee F, Pezhouh MK, Peters NA, Hruban RH, He J,
Makary MA, et al: Patients with a resected pancreatic mucinous
cystic neoplasm have a better prognosis than patients with an
intraductal papillary mucinous neoplasm: A large single institution
series. Pancreatology. 17:490–496. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nilsson LN, Keane MG, Shamali A, Millastre
Bocos J, Marijinissen van Zanten M, Antila A, Verdejo Gil C, Del
Chiaro M and Laukkarinen J: Nature and management of pancreatic
mucinous cystic neoplasm (MCN): A systematic review of the
literature. Pancreatology. 16:1028–1036. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tanaka M, Fernández-Del Castillo C,
Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M
and Wolfgang CL: Revisions of international consensus Fukuoka
guidelines for the management of IPMN of the pancreas.
Pancreatology. 17:738–753. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Stark A, Donahue TR, Reber HA and Hines
OJ: Pancreatic cyst disease: A Review. JAMA. 315:1882–1893.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Postlewait LM, Ethun CG, McInnis MR,
Merchant N, Parikh A, Idrees K, Isom CA, Hawkins W, Fields RC,
Strand M, et al: Association of preoperative risk factors with
malignancy in pancreatic mucinous cystic neoplasms: a multicenter
study. JAMA Surg. 152:19–25. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Le Baleur Y, Couvelard A, Vullierme MP,
Sauvanet A, Hammel P, Rebours V, Maire F, Hentic O, Aubert A,
Ruszniewski P, et al: Mucinous cystic neoplasms of the pancreas:
Definition of preoperative imaging criteria for high-risk lesions.
Pancreatology. 11:495–499. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
European Study Group on Cystic Tumours of
the Pancreas. European evidence-based guidelines on pancreatic
cystic neoplasms. Gut. 67:789–804. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fritz S, Hackert T, Hinz U, Hartwig W,
Büchler MW and Werner J: Role of serum carbohydrate antigen 19-9
and carcinoembryonic antigen in distinguishing between benign and
invasive intraductal papillary mucinous neoplasm of the pancreas.
Br J Surg. 98:104–110. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Pezzilli R, Calculli L, Melzi d'Eril G and
Barassi A: Serum tumor markers not useful in screening patients
with pancreatic mucinous cystic lesions associated with malignant
changes. Hepatobiliary Pancreat Dis Int. 15:553–557.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Luo G, Liu C, Guo M, Cheng H, Lu Y, Jin K,
Liu L, Long J, Xu J, Lu R, et al: Potential biomarkers in lewis
negative patients with pancreatic cancer. Ann Surg. 265:800–805.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu L, Xu H, Wang W, Wu C, Chen Y, Yang J,
Cen P, Xu J, Liu C, Long J, et al: A preoperative serum signature
of CEA+/CA125+/CA19-9 ≥1000 U/ml indicates poor outcome to
pancreatectomy for pancreatic cancer. Int J Cancer. 136:2216–2227.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Felder M, Kapur A, Gonzalez-Bosquet J,
Horibata S, Heintz J, Albrecht R, Fass L, Kaur J, Hu K, Shojaei H,
et al: MUC16 (CA125): Tumor biomarker to cancer therapy, a work in
progress. Mol Cancer. 13(129)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nagashio Y, Hijioka S, Mizuno N, Hara K,
Imaoka H, Bhatia V, Niwa Y, Tajika M, Tanaka T, Ishihara M, et al:
Combination of cyst fluid CEA and CA 125 is an accurate diagnostic
tool for differentiating mucinous cystic neoplasms from intraductal
papillary mucinous neoplasms. Pancreatology. 14:503–509.
2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li WL, Xu YD, Han X, Wu WC and Lou WH:
Pancreatic Surgery of Chinese Academic Society of Young Surgeons.
Clinical analysis and prognosis factors of malignancy in the
patients with mucinous cystic neoplasms of the pancreas. Zhonghua
Wai Ke Za Zhi. 58:225–229. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
15
|
Luo G, Fan Z, Cheng H, Jin K, Guo M, Lu Y,
Yang C, Fan K, Huang Q, Long J, et al: New observations on the
utility of CA19-9 as a biomarker in Lewis negative patients with
pancreatic cancer. Pancreatology. 18:971–976. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Goh BK, Tan DM, Thng CH, Lee SY, Low AS,
Chan CY, Wong JS, Lee VT, Cheow PC, Chow PK, et al: Are the Sendai
and Fukuoka consensus guidelines for cystic mucinous neoplasms of
the pancreas useful in the initial triage of all suspected
pancreatic cystic neoplasms? A single-institution experience with
317 surgically-treated patients. Ann Surg Oncol. 21:1919–1926.
2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhao ZM, Jiang N, Gao YX, Yin ZZ, Zhao GD,
Tan XL, Xu Y and Liu R: Clinical diagnosis and management of
pancreatic mucinous cystadenoma and cystadenocarcinoma:
Single-center experience with 82 patients. World J Gastrointest
Oncol. 12:642–650. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nagula S, Kennedy T, Schattner MA, Brennan
MF, Gerdes H, Markowitz AJ, Tang L and Allen PJ: Evaluation of cyst
fluid CEA analysis in the diagnosis of mucinous cysts of the
pancreas. J Gastrointest Surg. 14:1997–2003. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Brugge WR, Lewandrowski K,
Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, del Castillo CF
and Warshaw AL: Diagnosis of pancreatic cystic neoplasms: A report
of the cooperative pancreatic cyst study. Gastroenterology.
126:1330–1336. 2004.PubMed/NCBI View Article : Google Scholar
|
